Nemours 2025 Gala Supports Pediatric Cancer Research

May 29, 2025

Epi One CEO Michael Marquardt recently had the honor of attending the annual gala of the Nemours Children’s Health System with his wife Claire, who serves on its Board. The gala celebrates the research that is carried out to help cure pediatric cancers, and was held at the beautiful Longwood Gardens.

Nemours has a vision to reimagine children’s health and is addressing the social, economic, behavioral and environmental factors that affect kids every day. It advocates for health reforms, raising awareness of the issues facing young people and advancing policies with lasting impact for generations to come.

Proceeds from the ‘Night with Nemours’ Gala benefit the organisation’s new state-of-the-art Lisa Dean Moseley Foundation Institute for Cancer and Blood Disorders. With world-acclaimed physicians and scientists and new standards of care and treatment, the Moseley Institute is enhancing pediatric therapies locally and globally and making a significant impact on the lives of countless children and families. The new space will allow physicians and researchers to care for more children in an environment that transforms the patient experience, and will address the need for service consolidation while accommodating evolving clinical trials, research, and training programs.

The evening itself was held at the exceptionally beautiful Longwood Gardens, which has 200 acres of lush, formal gardens, open meadows, and breathtaking Brandywine Valley vistas.

Pictured below Michael at the Nemours 2025 Gala.

The Gala was held at Longwood Gardens.

Michael with his wife Claire, who serves on the Nemours Board.

MORE NEWS

Epi One Debuts Early Detection Assay Data at AACR 2025 Annual Meeting

Last week marked a milestone for Epi One: we presented for the first time at the American Association ...

American Cancer Society Medal of Honor Ceremony

Epi One CEO Michael Marquardt had the privilege of attending the American Cancer Society Medal of Honor ceremony ...

Epi One March Update

Epi One CEO Michael Marquardt provides an update on the latest news on developments in our current laboratory, ...

Epi One to Present Poster Session at AACR Conference

We are delighted to confirm that we will be presenting a poster session at this year's American Association ...

Epi One Raises $2.1 Million in Successful Equity Crowdfunding Campaign

Epi One, a trailblazer in cancer diagnostics, is thrilled to announce the successful conclusion of its equity crowdfunding ...

Transforming Early Cancer Detection: Latest Webinar Highlights

At Epi One, we're on a mission to revolutionize how cancer is detected and diagnosed. During our recent ...

Join Us for Epi One’s Final Investment Webinar – A Conversation with CEO Michael Marquardt and Chief Scientist & Founder Dr. Fang

As our StartEngine campaign enters its final weeks, we're excited to invite you to a special webinar event ...

Epi One: Top Reasons to Invest Today

7 Reasons to Invest in Epi One: Transforming Cancer Detection Imagine a world where a simple test could ...

Webinar Recap: Transforming Lives Through Early Cancer Detection

At Epi One, we're on a mission to change the landscape of cancer detection. Our recent webinar, led ...

Market Opportunity with Epi One

Market Opportunity with Epi One We believe Epi One is at the vanguard of the rapidly evolving cancer ...
Scroll to Top